Sugi Predict

Sugi Predict / Compounds / SCHEMBL246148

SCHEMBL246148

SCHEMBL246148

CC(C)n1c(C=O)c(-c2ccc(F)cc2)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 4/20 0.58
▸ SIRT6 Q8N6T7 2/20 0.58
▸ HMGCR P04035 2/20 0.58
▸ ABCC3 O15438 1/20 0.58
▸ ABCB11 O95342 1/20 0.58
▸ PGR P06401 1/20 0.58
▸ ADORA3 P0DMS8 1/20 0.58
▸ RXRA P19793 1/20 0.58
▸ TBXA2R P21731 1/20 0.58
▸ CCKAR P32238 1/20 0.58
▸ ADRA1A P35348 1/20 0.58
▸ PTGS2 P35354 1/20 0.58
▸ NR4A2 P43354 1/20 0.58
▸ PDE4D Q08499 1/20 0.58
▸ SLC10A1 Q14973 1/20 0.58
▸ ALDH1A1 P00352 3/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29670998 0.87 CYP2C9 (0.60) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL5847130 0.87 CYP2C9 (0.60) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL29999171 0.87 CYP2C9 (0.60) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL5847132 0.87 CYP2C9 (0.60) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL13208119 0.86 HMGCR (0.58) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL8846336 0.86 CYP2C9 (0.55) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL12073720 0.85 CYP2C9 (0.60) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL9763495 0.85 CYP2C9 (0.44) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL9441761 0.84 HMGCR (0.56) CYP2C9SIRT6HMGCRABCC3ABCB11
SCHEMBL22894603 0.84 CYP2C9 (0.56) CYP2C9SIRT6HMGCRABCC3ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788342-B1 PROCESS FOR THE PREPARATION OF A STATIN PRECURSOR DSM SINOCHEM PHARM NL BV (NL) 2018-01-24 — — EP claimed
EP-2665722-B1 PROCESS FOR THE PREPARATION OF DIOL SULFONES DSM SINOCHEM PHARM NL BV (NL) 2016-08-17 — — EP claimed
CN-103313984-B Methyl tetrazolium sulfide and sulfone DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2016-01-13 — — CN claimed
US-9150562-B2 Process for the preparation of diol sulfones DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2015-10-06 — — US claimed
EP-2665721-B1 METHYLTETRAZOLE SULFIDES AND SULFONES DSM SINOCHEM PHARM NL BV (NL) 2015-07-08 — — EP claimed
US-20140357864-A1 PROCESS FOR THE PREPARATION OF A STATIN PRECURSOR DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2014-12-04 — — US claimed
US-20140343292-A1 PROCESS FOR THE PREPARATION OF A THIOPRECURSOR FOR STATINS DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2014-11-20 — — US claimed
US-8865900-B2 Methyltetrazole sulfides and sulfones DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2014-10-21 — — US claimed
EP-2788341-A1 PROCESS FOR THE PREPARATION OF A THIOPRECURSOR FOR STATINS DSM Sinochem Pharmaceuticals Netherlands B.V. (NL) 2014-10-15 — — EP claimed
EP-2788342-A1 PROCESS FOR THE PREPARATION OF A STATIN PRECURSOR DSM Sinochem Pharmaceuticals Netherlands B.V. (NL) 2014-10-15 — — EP claimed
EP-2665721-A1 METHYLTETRAZOLE SULFIDES AND SULFONES DSM Sinochem Pharmaceuticals Netherlands B.V. (NL) 2013-11-27 — — EP claimed
US-20130303779-A1 PROCESS FOR THE PREPARATION OF DIOL SULFONES DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2013-11-14 — — US claimed
US-20130296563-A1 METHYLTETRAZOLE SULFIDES AND SULFONES DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2013-11-07 — — US claimed
CN-103328470-A Process for the preparation of diol sulfones DSM SINOCHEM PHARM NL BV 2013-09-25 — — CN claimed
CN-103313984-A Methyltetrazole sulfides and sulfones DSM SINOCHEM PHARM NL BV 2013-09-18 — — CN claimed
WO-2013083719-A1 PROCESS FOR THE PREPARATION OF A THIOPRECURSOR FOR STATINS DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2013-06-13 — — WO claimed
WO-2013083718-A1 PROCESS FOR THE PREPARATION OF A STATIN PRECURSOR DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2013-06-13 — — WO claimed
WO-2012098050-A1 METHYLTETRAZOLE SULFIDES AND SULFONES DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2012-07-26 — — WO claimed
WO-2012098048-A1 PROCESS FOR THE PREPARATION OF DIOL SULFONES DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) 2012-07-26 — — WO claimed
EP-1634870-A1 Process and intermediates for the selective synthesis of Fluvastatin Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) 2006-03-15 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357864-A1 PROCESS FOR THE PREPARATION OF A STATIN PRECURSOR HMGCR, PCSK9, DHCR7 CYP2C9 143/4885SIRT6 889/4885HMGCR 1/4885
US-20130303779-A1 PROCESS FOR THE PREPARATION OF DIOL SULFONES STS, DHCR7, TST CYP2C9 40/4885SIRT6 2623/4885HMGCR 5/4885
US-20140343292-A1 PROCESS FOR THE PREPARATION OF A THIOPRECURSOR FOR STATINS HMGCR, TPMT, GRHPR CYP2C9 114/4885SIRT6 775/4885HMGCR 1/4885
US-20130296563-A1 METHYLTETRAZOLE SULFIDES AND SULFONES TST, STS, TPMT CYP2C9 49/4885SIRT6 3693/4885HMGCR 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.